Last updated on May 2018

CAR-T Therapy for Central Nervous System B-cell Acute Lymphocytic Leukemia

Brief description of study

This study will evaluates the safety and efficacy of Chimeric antigen receptor T cells (CAR-T) in treating central nervous system B-cell acute lymphocytic leukemia.

Detailed Study Description

CNS leukemia is defined as unequivocal evidence of leukemic blasts in the cerebrospinal fluid by cytology or flow cytometry; cranial palsies or a nonhemorrhagic mass seen in cranial computed tomography or magnetic resonance imaging because of infiltration by leukemia cells

Clinical Study Identifier: NCT03064269

Find a site near you

Start Over